Jennison Associates LLC Bio N Tech Se Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$123.25 - $186.24 $22.9 Million - $34.6 Million	-185,818 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$126.25 - $231.85 $371 Million - $682 Million	-2,940,921 Reduced 94.06%	185,818 $31.7 Million
Q4 2021 Feb 08, 2022	SELL	$216.64 - $362.52 $205 Million - $343 Million	-946,831 Reduced 23.24%	3,126,739 $806 Million
Q3 2021 Nov 09, 2021	BUY	$205.93 - $447.23 $786 Million - $1.71 Billion	3,814,715 Added 1473.69%	4,073,570 $1.11 Billion
Q2 2021 Aug 12, 2021	SELL	$113.32 - $241.49 $4.5 Million - $9.59 Million	-39,700 Reduced 13.3%	258,855 $58 Million
Q1 2021 May 11, 2021	BUY	$85.73 - $119.5 $25.6 Million - $35.7 Million	298,555 New	298,555 $32.6 Million

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.